Answer
Cobicistat-containing medicines are expected to increase the risk of systemic side effects from deflazacort; the combination should be avoided unless benefits outweigh this increased risk, in which case patients should be monitored for systemic corticosteroid side effects.
Sources for this answer
- Calcort 6mg TabletsNeon Healthcare Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 3Document updated
Sources checked